Fundraising FoxVersant Ventures — 2022 Investments
6 investments dated 2022 · listed companies and verified rows first · show all
Nested Therapeutics is a precision oncology company developing small-molecule cancer therapeutics by identifying overlooked driver mutations and novel binding pockets through a drug discovery platform combining genomics, computational biophysics, machine learning, and chemical biology.
AI & Machine LearningBiotechHealthtech
Arvin Dar(Co-founder & Board Observer)inKevan Shokat(Scientific Co-founder)Klaus Hoeflich(Co-founder & former Chief Scientific Officer)inDarrin Miles(Chief Executive Officer)inPhilip Komarnitsky(Chief Medical Officer)inTanja Weber(Chief Business Officer)in
Co-investorsForesite CapitalSixty Degree CapitalCowen Healthcare InvestmentsGoldman SachsSection 32
Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechWaltham, US
Judith Lieberman(Co-Founder)Daniel Koerwer(Executive Officer)inMichael Crackower(Executive Officer)inZachary McNealy(Executive Officer)Marcelo Bigal, M.D., Ph.D.(President and Chief Executive Officer)
BoardJosh Resnick(Director)in
Board seatMarkus WarmuthJerel Davis· per SEC Form D
Co-investorsAndreessen HorowitzGV (Google Ventures)RA CapitalSoftBank Vision FundAlexandriaBiotechnology Value Fund+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
March Therapeutics, Inc.Launchpad Therapeutics, Inc.Vector BioPharma
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.